 An HPLC-MS/MS assay is described to determine temocillin total and free concentrations in serum.  The method is rapid, sensitive (LOQ = 1 mg/L), selective, precise and exact, with no interferences.  The method was successfully applied to clinical samples.
Introduction
Temocillin is a -lactam antibiotic active against gram-negative bacteria, including -lactamase producers [1, 2] .
It is currently indicated for the treatment of septicemia, urinary tract infections, and lower respiratory tract infections [3] . In the recent years the interest on this drug has been greatly enhanced, due to the increased incidence of infections caused by microorganisms producing extended-spectrum -lactamases. This makes temocillin a strategic and interesting alternative to carbapenems, especially with the current driving force to spare the use of these drugs [2] .
Pharmacodynamic studies predict that therapeutic success with -lactams depends on the time during which their free concentration in serum remains above the MIC of the offending organism [4] . Dosage should thus be adapted to take into account not only the bacterial susceptibility, but also the rate of elimination of the drug. There is evidence of a wide interindividual variability in the temocillin serum levels so that standard dosing regimens may not be adequate in special patient populations such as intensive-care and end-stage renal disease patients [5, 6] .
These patients may benefit from individualizing dose regimens based on therapeutic drug monitoring.
Two validated assays (HPLC-UV) have been described in the literature to quantify temocillin. The first one was used for controlling purity and detecting related substances in temocillin batches [7] , and the other one, for quantifying the drug in serum [8] . The later method involves a laborious sample preparation with solid-phase extraction to eliminate possibly interfering substances and was validated for the total concentration only. The present work aims at validating a new, rapid, sensitive and selective HPLC-MS/MS method for determination of both total and unbound concentrations of temocillin in serum.
Materials and methods
Temocillin (∼68% R and ∼32% S isomers; NEGABAN®) were obtained from Eumedica s.a. (Brussels, Belgium). Ticarcillin disodium (∼55% R and ∼45% S isomers; internal standard, IS) was from Sigma-Aldrich Inc. (St. Louis, MO, USA). Both molecules are chemically stable for at least 24 h at 37°C [9, 10] and much longer at 4°C [11, 12] . HPLC/MS-grade methanol and acetonitrile were purchased from J.T. Baker (Deventer, The assay was fully validated according to the U.S. Food and Drug Administration (FDA) guidelines [13] .
Statistics were performed using JMP software (SAS Institute, Cary, NC, USA). The linearity has been assessed over the 7 and 9 calibrators (total and unbound concentration, respectively), in 5 replicates over 3 days. The limit of quantification (LOQ) was calculated as the minimum concentration at which temocillin can be reliably quantified with a precision ≤ 20% and accuracy within -20-20%. The limit of detection (LOD) was calculated as the smallest detectable peak above baseline noise (signal-to-noise ratio > 3:1). Inter-assay precision and accuracy were assessed on QC samples and the LOQ, in replicates of 5 for 3 days. To determine intra-assay accuracy and precision, the same samples were analyzed 5 times. Extraction efficiency of temocillin from serum was performed by comparing concentrations recovered from samples treated as described above for the determination of total concentration with unextracted calibrators (6 replicates for the 3 QC concentrations). Matrix effect was assessed against the QC samples using the post-extraction addition technique using 6 different drug-free serum samples for each aliquot [14] . The suitability of IS to minor matrix effect has been assessed by comparing calibration curves made in HPLC solvent A and in 6 different plasma with and without IS.
Results
The correlation coefficient (R²) for each calibration curve was >0.99, with a mean value of 0.993 and 0.995 for the total (n=15) and unbound (n=15) temocillin concentration, respectively. LOQ and LOD were found to be 1 and 0.10 mg/L (total concentration) and 0.50 and 0.05 mg/L (unbound concentration). As shown in Figure 1 , the retention times (RT) were 3.45 and 3.50 min for temocillin and IS, respectively. For the total concentrations, inter-assay (3 days; n=15) precision and accuracy ranged from 6.48 to 8.88% and from 2.26 to 11.64% respectively, while the intra-assay (3 days; n=5) precision and accuracy ranged from 7.14 to 9.18% and from 6.86 to 13.91% respectively. For the unbound concentrations, inter-assay (3 days; n=15) precision and accuracy ranged from 3.4 to 4.8% and from 3.3 to 7.6%, with an intra-assay (3 days; n=5) precision and accuracy ranging from 1.1 to 6.7% and from 8.4 to 12.5%, respectively.
Temocillin extraction efficiency ranged from 85.8 to 99.4% with a precision ranging from 7.5 to 11.9%, and appeared concentration independent. No interfering peak greater than 20% of the response at the LOQ was detected at the m/z transitions and RT of temocillin and IS. Typical ion chromatograms of extracts from blank plasma sample, plasma spiked with temocillin (1 mg/L) and ticarcillin (40 mg/L) are shown in Figure 1 .
At the three QC levels, matrix effect was acceptable, ranging from -36.2 to -17.3% ion suppression for both temocillin and IS. This effect was significantly corrected using ticarcillin as IS. Indeed, the function slope between calibration curves made in HPLC solvent A and different plasma was comparable (mean=0.571; CV= 4.8%; n=7). The results of these experiments suggested that matrix effects have minimal influence on the results.
This method was then applied to determine the concentration-time profile of total and free temocillin for temocillin in the serum of an end-stage renal disease patient, having received 2 g of temocillin by IV route. As shown in Figure 2 , total concentration matched those determined by a previously validated HPLC-UV method.
Free concentrations oscillated between 24 % at 0.5 h to 13 % at 44 h and the free AUC represented 14% of the total value. These observations are in line with what is stated in the summary of product characteristics, namely that the free fraction depends on the total concentration due to saturation of binding sites on serum proteins and that the protein binding is around 85 % for total concentrations around 16 mg/L [3] . The graph shows the total and free concentrations as determined by HPLC-MS/MS and the total concentration determined by HPLC-UV using the previously described method [8] .
Conclusion
The HPLC-MS/MS method described in this work for the quantification of total and free temocillin in human serum proved rapid, sensitive, and selective, with a LOQ of 1 mg/L. As MS/MS detection is highly specific, this method has probably a wider applicability to different clinical situations than the previously developed HPLC-UV assay [8] , like in patients receiving other medications or in haemodialysis patients who accumulate acidic metabolites [15] . 
